Horizon Kinetics Asset Management LLC reduced its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Get Rating) by 2.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 399,880 shares of the biopharmaceutical company’s stock after selling 8,666 shares during the period. Horizon […]
Hikari Tsushin Inc. boosted its holdings in Royalty Pharma plc (NASDAQ:RPRX – Get Rating) by 469.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,220 shares of the biopharmaceutical company’s stock after buying an additional 1,830 shares during the quarter. Hikari Tsushin Inc.’s […]
Edge Capital Group LLC lifted its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Get Rating) by 15.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,819 shares of the biopharmaceutical company’s stock after acquiring an additional 2,721 […]
Royalty Pharma plc (NASDAQ:RPRX – Get Rating) has been given a consensus recommendation of “Buy” by the eight research firms that are presently covering the company, Marketbeat.com reports. Six analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have covered the stock in the last year is […]